BiomarkersHumans
TARGETED SCREENING FOR LIVER FIBROSIS: IDENTIFYING HIGH-RISK ADULTS FOR TRANSIENT ELASTOGRAPHY EVALUATION
GSA 2024 Abstract
Abstract
Non-alcoholic fatty liver disease (NAFLD) poses a significant clinical concern, impacting over 30% of the general population and leading to potentially reversible liver fibrosis, cirrhosis, and physical frailty.